Showing 1 - 20 results of 243 for search '(( significantly ((lower decrease) OR (_ decrease)) ) OR ( significant adverse decrease ))~', query time: 0.45s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    S1 File - by Changxu Wang (17826805)

    Published 2024
    “…Compared with the GA group, the VAS scores at 6 hours, 12 hours, and 24 hours after surgery in the TAP+GA group were significantly decreased, and the intraoperative consumption of remifentanil and the numbers of postoperative analgesic pump presses were significantly reduced (<i>P</i><0.05). …”
  9. 9

    The flow chart of the study. by Changxu Wang (17826805)

    Published 2024
    “…Compared with the GA group, the VAS scores at 6 hours, 12 hours, and 24 hours after surgery in the TAP+GA group were significantly decreased, and the intraoperative consumption of remifentanil and the numbers of postoperative analgesic pump presses were significantly reduced (<i>P</i><0.05). …”
  10. 10

    The Laboratory Animal Flow Diagram. by Xueqin lu (22250795)

    Published 2025
    “…This unique design enables both THR-β activation and targeted delivery to hepatocytes, which significantly reduces the risk of adverse effects related to increased systemic thyroid hormone activity. …”
  11. 11

    <sup>1</sup>H NMR spectra for kylo-0603. by Xueqin lu (22250795)

    Published 2025
    “…This unique design enables both THR-β activation and targeted delivery to hepatocytes, which significantly reduces the risk of adverse effects related to increased systemic thyroid hormone activity. …”
  12. 12

    <sup>13</sup>C NMR spectra for Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    “…This unique design enables both THR-β activation and targeted delivery to hepatocytes, which significantly reduces the risk of adverse effects related to increased systemic thyroid hormone activity. …”
  13. 13

    The structures of T3 and Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    “…This unique design enables both THR-β activation and targeted delivery to hepatocytes, which significantly reduces the risk of adverse effects related to increased systemic thyroid hormone activity. …”
  14. 14

    Synthesis process of Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    “…This unique design enables both THR-β activation and targeted delivery to hepatocytes, which significantly reduces the risk of adverse effects related to increased systemic thyroid hormone activity. …”
  15. 15

    ESI-HRMS spectra for Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    “…This unique design enables both THR-β activation and targeted delivery to hepatocytes, which significantly reduces the risk of adverse effects related to increased systemic thyroid hormone activity. …”
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20